Skip to content

13F-HR filed by Cormorant Asset Management, LP

Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 120 holding rows worth $4,488,679,000.

Accession
0001583977-21-000005
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 120 entries on the cover page, a total value of $4,488,679,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,488,679,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS2,000,000$441,880,000thousands by filing dateput
SPY78462F103SHS1,000,000$396,330,000thousands by filing dateput
ATEA PHARMACEUTICALS INC04683R106COMMON STOCK6,411,355$395,901,000thousands by filing date
TURNING PT THERAPEUTICS90041T108COM2,750,000$260,122,000thousands by filing date
DESIGN THERAPEUTICS INC25056L103COM5,114,850$146,409,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH1,000,000$135,650,000thousands by filing dateput
BRIDGEBIO PHARMA INC10806X102COM2,168,909$133,605,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS4,720,000$132,254,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock2,525,000$115,847,000thousands by filing date
BIOATLA INC09077B104COM2,192,060$109,927,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM3,195,544$105,084,000thousands by filing date
C4 THERAPEUTICS INC12529R107COM STK2,490,065$92,107,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM1,866,108$80,075,000thousands by filing date
EDGEWISE THERAPEUTICS INC28036F105COM2,340,914$74,307,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK881,770$65,022,000thousands by filing date
ZYMEWORKS INC98985W102COM2,000,000$63,160,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,368,550$60,723,000thousands by filing date
OMEROS CORP682143102COM3,300,030$58,741,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM1,437,807$55,844,000thousands by filing date
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK1,714,269$55,251,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock2,464,545$53,752,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock2,000,000$50,400,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM275,000$47,108,000thousands by filing date
NOVAVAX INC670002401COM NEW250,000$45,328,000thousands by filing date
CHEMOCENTRYX INC16383L106COM850,000$43,554,000thousands by filing date
AXONICS INC05465P101COM693,000$41,504,000thousands by filing date
DERMTECH INC24984K105COM800,000$40,632,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A400,000$39,880,000thousands by filing date
IGM BIOSCIENCES INC449585108COM495,769$38,021,000thousands by filing date
ACCELERON PHARMA INC00434H108COM275,000$37,293,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock1,230,000$37,195,000thousands by filing date
LONGBOARD PHARMACEUTICALS IN54300N103COM2,356,000$37,193,000thousands by filing date
PROMETHEUS BIOSCIENCES INC74349U108COM2,098,024$36,623,000thousands by filing date
PRAXIS PRECISION MEDICINES I74006W108COM1,074,145$35,189,000thousands by filing date
Veru Inc92536C103Common Stock3,000,000$32,325,000thousands by filing date
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock1,267,167$28,815,000thousands by filing date
908 DEVICES INC COM65443P102Stock545,322$25,919,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM300,000$24,075,000thousands by filing dateput
PLIANT THERAPEUTICS INC729139105COM611,409$24,047,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM247,200$24,035,000thousands by filing date
APTOSE BIOSCIENCES INC COM03835T200Stock4,000,000$23,900,000thousands by filing date
PHARVARIS NVN69605108COMMON STOCK864,143$23,811,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM185,000$22,914,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK2,750,000$22,742,000thousands by filing date
MORPHIC HLDG INC61775R105COM350,000$22,148,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM500,000$21,815,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM742,549$21,541,000thousands by filing date
CABALETTA BIO INC12674W109COMMON STOCK1,904,424$21,139,000thousands by filing date
AGENUS INC00847G705COM NEW7,750,000$21,080,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO1,000,000$20,580,000thousands by filing date
ZAI LAB LTD ADR98887Q104ADR150,000$20,014,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM900,000$19,872,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM750,000$19,268,000thousands by filing date
HUMANIGEN INC444863203COM NEW1,000,000$19,100,000thousands by filing date
CONNECT BIOPHARMA HLDGS LTD207523101SHS1,000,000$18,500,000thousands by filing date
OMEROS CORP682143102COM1,000,000$17,800,000thousands by filing datecall
ALBIREO PHARMA INC01345P106COMMON STOCK500,000$17,625,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock85,000$17,594,000thousands by filing date
ELEDON PHARMACEUTICALS INC28617k101COM1,415,500$15,146,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM462,205$14,185,000thousands by filing date
ANAPTYSBIO INC032724106COM650,000$14,008,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM171,775$13,749,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM200,000$13,670,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,000,000$13,180,000thousands by filing date
GALECTO INC36322Q107COM2,150,732$13,066,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR100,000$12,888,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM570,600$11,937,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock200,000$11,324,000thousands by filing date
THERAVANCE BIOPHARMA INCG8807B106COM550,000$11,226,000thousands by filing date
AVEO PHARMACEUTICALS INC053588307COM1,500,000$10,980,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR100,000$10,919,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM300,000$10,254,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock300,000$10,218,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM125,000$9,196,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS800,000$8,984,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM200,000$8,968,000thousands by filing date
BCTG ACQUISITION CORP05492W103COM800,000$8,896,000thousands by filing date
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock200,000$8,676,000thousands by filing date
UNIQURE NVN90064101SHS250,000$8,422,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR30,000$8,262,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock848,382$7,848,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM459,144$7,672,000thousands by filing date
MERUS N VN5749R100COM350,000$7,311,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock600,000$7,104,000thousands by filing date
AKOUOS INC00973J101COM499,989$6,935,000thousands by filing date
GENETRON HLDGS LTD37186H100ADS300,000$6,438,000thousands by filing date
GEMINI THERAPEUTICS INC36870G105CMN475,000$6,436,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM150,000$6,250,000thousands by filing date
QUOTIENT LTDG73268107SHS1,500,000$5,520,000thousands by filing date
PROTARA THERAPEUTICS INC74365U107COM STK350,000$5,509,000thousands by filing date
IMMUNOVANT INC45258J102COM337,048$5,406,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN500,000$5,285,000thousands by filing date
THERAPEUTICS ACQUISITION COR88339T103COM CL A500,000$5,255,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM70,000$5,217,000thousands by filing date
5 01 ACQUISITION CORP33836P105CMN500,000$4,988,000thousands by filing date
VESPER HEALTHCARE ACQSTN COR92538T203UNIT 99/99/9999400,000$4,620,000thousands by filing date
ATRECA INC04965G109COM293,500$4,499,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICSG4444C102COM430,000$4,386,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK125,000$3,814,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock150,000$3,762,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM346,524$3,587,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM400,000$3,540,000thousands by filing date
KADMON HLDGS INC48283N106COM750,000$2,918,000thousands by filing date
ALLAKOS INC01671P100COM25,000$2,870,000thousands by filing date
NUVATION BIO INC COM CL A67080N101Stock234,445$2,450,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM422,167$2,419,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A130,000$2,406,000thousands by filing date
TRICIDA INC89610F101COM427,975$2,264,000thousands by filing date
GRACELL BIOTECHNOLOGIES INC38406L103ADR125,000$1,925,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR256,649$1,863,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM150,000$1,389,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW20,000$1,388,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM103,980$895,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM10,000$824,000thousands by filing date
IMV INC44974L103COM234,374$772,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock200,000$584,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U102*W EXP 06/09/202133,331$563,000thousands by filing date
OUTLOOK THERAPEUTICS INC69012T115*W EXP 02/18/202416,666$421,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM20,000$400,000thousands by filing date
NUVATION BIO INC67080N119WARR83,332$222,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001583977-21-000005this filing2021-05-17acceptance time not in the bulk data set